Pharmaceuticals firm Ajanta Pharma Announced Q1FY23 Result : Revenue from operations at Rs. 951 cr. against Rs. 748 cr.; up 27%. EBITDA at Rs. 222 cr. against Rs. 220 cr.; EBITDA at 23% of Revenue from Operations. Profit after tax at Rs. 175 cr. against Rs. 174 cr.; PAT at 18% of Revenue from Operations. Result PDF